Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular
Pharma
Amgen's Repatha meets the mark in CV primary prevention trial
On the heels of a label expansion in August, Amgen is touting another potential avenue to extend the value of its aging PCSK9 cholesterol med Repatha.
Fraiser Kansteiner
Oct 2, 2025 11:26am
Novartis to lay off 427 staffers amid marketing model rework
Mar 18, 2025 10:19am
A heartwarming review of cardiovascular news, most-loved stories
Feb 14, 2025 9:00am
Boehringer tops reputation rankings among CV patient groups
Oct 31, 2024 11:32am
Viatris lays out $25M to tackle marketing of Lexicon's Inpefa
Oct 17, 2024 10:17am
Novo Nordisk rekindles heart failure hopes for semaglutide
Aug 30, 2024 11:48am
